FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2972250283> ?p ?o ?g. }

• W2972250283 endingPage "4231" @default.
• W2972250283 startingPage "4231" @default.
• W2972250283 abstract "Abstract The introduction of BCR-ABL tyrosine kinase inhibitors has revolutionized the treatment of chronic myeloid leukemia (CML). A major clinical aim remains the identification and elimination of low-level disease persistence, termed minimal residual disease. Disease persistence suggests, that despite targeted therapeutic approaches, BCR-ABL-independent mechanisms exist which sustain the survival of a small population of cells, termed leukemic stem cells (LSC). We previously identified CD93 expression as a promising biomarker of LSC in chronic phase (CP)-CML. Our group has described the long term self-renewal potential of Lin-CD34+93+ CP-CML cells compared to their Lin-CD34+93- counterparts through LTCIC assays (n=3, p<0.0001) and NSG engraftment models (3.5-30-fold increased in engraftment with Lin-CD34+93+ cells, p<0.03). We hypothesized that CD93+-selected cells would represent a more immature functional phenotype compared to CD93- selected cells. The aim of this study was to characterize differences in the gene expression profile between CD93+ and CD93- CML LSC populations and determine heterogeneity of each population at a single cell level. To interrogate this, we initially identified CP-CML subpopulations with the greatest functional capability compared to normal. Normal and CP-CML samples were FACS-sorted into HSC/LSC, CMP, GMP, and MEP sub-populations. Results suggest a significant change in functional status between normal and CP-CML subpopulations within the HSC/LSC compartment (lin-CD34+CD38-CD45RA-CD90+), where CML LSC demonstrated significantly increased proliferation (14 fold expansion; P<0.001) compared to normal HSC (no expansion) after 5 days in vitro culture in physiological growth factors. In addition, equivalent numbers of CML LSC produce ~4-fold more colonies in colony forming cell (CFC) assays than normal HSC (329±56 versus 86±17 per 2,000 cells, respectively (p<0.05)). Furthermore, fluorescence in situ hybridization demonstrated that >90% of lin-CD34+CD38-CD45RA-CD90+ CML LSC from all patient samples were BCR-ABL positive. Subsequent experiments were confined to the LSC population. We hypothesized that lin-CD34+CD38-CD90+CD93- CML cells would have a more mature gene expression profile compared to lin-CD34+CD38-CD90+CD93+ cells. CP-CML cells were sorted into (1) lin-CD34+, (2) lin-CD34+CD38-CD90+CD93- and (3) lin-CD34+CD38-CD90+CD93+ populations. RNA was harvested at baseline from bulk populations (1) to (3) and cDNA was generated from single cells using the Fluidigm C1 autoprep system. Using Fluidigm technology, quantitative PCR of 90 lineage-specific and cell survival genes was performed within all populations of cells (1) to (3) in 'bulk' samples (n=3), and at single cell level (n=123 CD93+, n=120 CD93-single cells; n=3 samples in total). Bulk sample analysis demonstrated a significant increase in expression of lineage commitment genes within the lin-CD34+CD38-CD90+CD93- population, as shown by increased expression of GATA1 (p=0.0007), and CBX8 (p=0.0002). The lin-CD34+CD38-CD90+CD93+ population displayed a less lineage-restricted profile with increased expression of CDK6 (p=0.05), HOXA6 (ns), CDKN1C (ns) and CKIT (p=0.0014), compared to the lin-CD34+CD38-CD90+CD93- population. Furthermore, the two populations could be segregated by differential gene expression through gene clustering. At a single cell level, differences were noted in the frequency of expression between lin-CD34+CD38-CD90+CD93- and lin-CD34+CD38-CD90+CD93+ populations, particularly in GATA1, TPOR, and VWF. Although a statistically significant change was demonstrated in gene expression between the lin-CD34+CD38-CD90+CD93- and lin-CD34+CD38-CD90+CD93+ populations in a number of genes, we were not able to segregate the populations by differential expression using gene clustering. This highlights the heterogeneous nature of the cell populations and the inability to distinctly characterize between the two populations at a single cell level. Our results validate CD93 as a potential biomarker to separate the primitive CP-CML LSC population and highlight key lineage and cell survival pathways that are altered in CML LSC. The results demonstrate the heterogeneity seen within gene expression at the single cell level, which may allow for further insight into the CML LSC compartment with further analyses. Disclosures Wheadon: GlaxoSmithKline: Research Funding. Copland:Shire: Honoraria; Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Bristol Myers Squibb: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Pfizer: Honoraria, Membership on an entity's Board of Directors or advisory committees; ARIAD: Honoraria, Membership on an entity's Board of Directors or advisory committees; Amgen: Honoraria." @default.
• W2972250283 created "2019-09-12" @default.
• W2972250283 creator A5032156036 @default.
• W2972250283 creator A5035887338 @default.
• W2972250283 creator A5050908023 @default.
• W2972250283 creator A5057534414 @default.
• W2972250283 creator A5072637924 @default.
• W2972250283 creator A5081853382 @default.
• W2972250283 date "2016-12-02" @default.
• W2972250283 modified "2023-09-27" @default.
• W2972250283 title "Gene Expression Profiling of CD93-Selected CP-CML Stem Cells Confirms Their Quiescent Character and Biomarker Potential" @default.
• W2972250283 doi "https://doi.org/10.1182/blood.v128.22.4231.4231" @default.
• W2972250283 hasPublicationYear "2016" @default.
• W2972250283 type Work @default.
• W2972250283 sameAs 2972250283 @default.
• W2972250283 citedByCount "0" @default.
• W2972250283 crossrefType "journal-article" @default.
• W2972250283 hasAuthorship W2972250283A5032156036 @default.
• W2972250283 hasAuthorship W2972250283A5035887338 @default.
• W2972250283 hasAuthorship W2972250283A5050908023 @default.
• W2972250283 hasAuthorship W2972250283A5057534414 @default.
• W2972250283 hasAuthorship W2972250283A5072637924 @default.
• W2972250283 hasAuthorship W2972250283A5081853382 @default.
• W2972250283 hasConcept C10205521 @default.
• W2972250283 hasConcept C109159458 @default.
• W2972250283 hasConcept C116716535 @default.
• W2972250283 hasConcept C153911025 @default.
• W2972250283 hasConcept C159912055 @default.
• W2972250283 hasConcept C203014093 @default.
• W2972250283 hasConcept C2778729363 @default.
• W2972250283 hasConcept C2779823535 @default.
• W2972250283 hasConcept C2780007613 @default.
• W2972250283 hasConcept C28328180 @default.
• W2972250283 hasConcept C2908647359 @default.
• W2972250283 hasConcept C502942594 @default.
• W2972250283 hasConcept C54355233 @default.
• W2972250283 hasConcept C71924100 @default.
• W2972250283 hasConcept C86803240 @default.
• W2972250283 hasConcept C99454951 @default.
• W2972250283 hasConceptScore W2972250283C10205521 @default.
• W2972250283 hasConceptScore W2972250283C109159458 @default.
• W2972250283 hasConceptScore W2972250283C116716535 @default.
• W2972250283 hasConceptScore W2972250283C153911025 @default.
• W2972250283 hasConceptScore W2972250283C159912055 @default.
• W2972250283 hasConceptScore W2972250283C203014093 @default.
• W2972250283 hasConceptScore W2972250283C2778729363 @default.
• W2972250283 hasConceptScore W2972250283C2779823535 @default.
• W2972250283 hasConceptScore W2972250283C2780007613 @default.
• W2972250283 hasConceptScore W2972250283C28328180 @default.
• W2972250283 hasConceptScore W2972250283C2908647359 @default.
• W2972250283 hasConceptScore W2972250283C502942594 @default.
• W2972250283 hasConceptScore W2972250283C54355233 @default.
• W2972250283 hasConceptScore W2972250283C71924100 @default.
• W2972250283 hasConceptScore W2972250283C86803240 @default.
• W2972250283 hasConceptScore W2972250283C99454951 @default.
• W2972250283 hasIssue "22" @default.
• W2972250283 hasLocation W29722502831 @default.
• W2972250283 hasOpenAccess W2972250283 @default.
• W2972250283 hasPrimaryLocation W29722502831 @default.
• W2972250283 hasRelatedWork W1985725392 @default.
• W2972250283 hasRelatedWork W2078555565 @default.
• W2972250283 hasRelatedWork W2084319477 @default.
• W2972250283 hasRelatedWork W2130198701 @default.
• W2972250283 hasRelatedWork W2565468786 @default.
• W2972250283 hasRelatedWork W2979651818 @default.
• W2972250283 hasRelatedWork W2998081307 @default.
• W2972250283 hasRelatedWork W3135794887 @default.
• W2972250283 hasRelatedWork W3198650332 @default.
• W2972250283 hasRelatedWork W4312530464 @default.
• W2972250283 hasVolume "128" @default.
• W2972250283 isParatext "false" @default.
• W2972250283 isRetracted "false" @default.
• W2972250283 magId "2972250283" @default.
• W2972250283 workType "article" @default.